|
Email |
palanker@stanford.edu |
Phone |
(650) 725-0059 |
URL |
https://web.stanford.edu/~palanker/ |
Address |
Hansen Experimental Physics Laboratory
452 Lomita Mall, room 135
Stanford, CA 94305-4085 |
Professional Interests
Optical and electronic technologies for diagnostic, therapeutic, surgical and prosthetic applications, primarily in ophthalmology:
- Electro-Neural interfaces: Photovoltaic Retinal Prosthesis; Electronic Control of Vasculature and of the Glands
- Optical Imaging and Spectroscopy: Interferometric detection of neural activity
- Laser-Tissue Interactions:
- Non-damaging retinal laser therapy
- Ultrafast laser surgery of transparent tissues
- Retinal plasticity:
- Cellular preservation and proliferation in response to therapy
- Transplanation of retinal cells and neural rewiring
Back to top »
Current research projects
Back to top »
Some of the previous research projects
- Electronic Control of Organs
- Retinal Plasticity - migration and rewiring of the retinal neurons
- Pulsed Electron Avalanche Knife (PEAK)
- Coherent Anti-Stokes Raman Scattering (CARS) Microscopy
- Optical detection of physiological stress (based on light scattering spectroscopy)
- Plasma-mediated electroporation
- Pulsed liquid microjet
- Near-field Infrared Microscopy with:
- Transient optical elements (using photo-induced reflectivity)
- Tapered fibers
- Solid-immersion microlenses
- ArF excimer laser-based system for vitreoretinal surgery and for skin debridement
- Laser-assisted in-vitro fertilization:
- Photolysis of zona pellucida using the ArF excimer laser-based system
- Thermolysis using a microheater-based system
- Laser poration of cellular membrane: parallel permeabilization of millions of cells using an array of microapertures
- Statistical approach to sub-wavelength measurements using an array of near-field apertures (This idea later inspired rapid DNA sequencing: SMRT™ technology)
Back to top »
Teaching
Back to top »
STARTUPS and Technology Transfer
More than 70 patents became foundation of 7 platform technologies transferred to industrial development and manufacturing via startups. The following technologies are currently in clinical use world-wide:
Others are in clinical trials: